Gapping up
In reaction to earnings/guidance:
- PRTY +9.3%, BNTX +9.2% (also to establish first regional hub in Asia Pacific region in Singapore), MX +5.7%, WB +4.4%, J +3.6%, CRNC +3.4%, ENR +2.9%, GEO +2.4%, VTRS +1.8%, UNVR +1.4%, DBD +1.3%, TSN +1.2%, DUK +1.1%
Other news:
- OFIX +8.6% (announces the expansion of its pediatric offerings with the U.S. Food and Drug Administration 510(k) clearance of the OrthoNext)
- MBIO +6.9% (FDA has accepted the Company's Investigational New Drug application to initiate a Phase 1/2 multicenter study to assess the safety, tolerability and efficacy of MB-106)
- LPI +4.4% (announces transaction of acquisition and divestiture) MAN +4.3% (increase semi-annual dividend to $1.26/share from $1.17/share)
- SJ +4.3% (signed a memorandum of understanding (MOU) with Beijing Douneng Maihuo Culture Media)
- SIC +1.9% (divests RDS segment to Interior Logic Group for $215 mln; updates outlook)
- ALT +1.4% (announces "positive" results from a preclinical study of AdCOVID in a SARS-CoV-2 challenge model of infection)
- COHU +1% (divests Printed Circuit Board Test business)
- STPC +1% (Benson Hill to become publicly listed through business combination with Star Peak Corp II)
Analyst comments:
- IHRT +4.6% (upgraded to Overweight from Neutral at JP Morgan)
- MGI +3.5% (upgraded to Neutral from Underweight at JP Morgan)
- SEDG +2.1% (upgraded to Buy from Neutral at BofA Securities)
- LYV +2% (upgraded to Buy from Hold at Jefferies)
- CREE +1.5% (upgraded to Neutral from Underweight at JP Morgan)
- LYFT +1.4% (upgraded to Outperform from Neutral at Daiwa Securities)
- CCOI +1.3% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- SBRA +1.1% (upgraded to Buy from Hold at Stifel)
- VCTR +1% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)